Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 2, 2011, Pages 365-374

  Tasali, Esra ^a   Chapotot, Florian ^a   Leproult, Rachel ^a   Whitmore, Harry ^a   Ehrmann, David A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; HYDROCORTISONE; LEPTIN; NORADRENALIN;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART MUSCLE METABOLISM; HEART RATE VARIABILITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; NORADRENALIN BLOOD LEVEL; OBESITY; OVARY POLYCYSTIC DISEASE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SYMPATHETIC FUNCTION;

ADULT; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; BODY MASS INDEX; CONTINUOUS POSITIVE AIRWAY PRESSURE; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HEMODYNAMICS; HORMONES; HUMANS; INSULIN; INSULIN RESISTANCE; OBESITY; PATIENT COMPLIANCE; POLYCYSTIC OVARY SYNDROME; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE;

EID: 79951701818     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1187     Document Type: Article

References (68)

1. Ehrmann DA 2005 Polycystic ovary syndrome. N Engl J Med 352:1223-1236
2. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R 1998 Prevalence of polycystic ovary syndrome in unselected Black and White women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078-3082 (Pubitemid 28500937)
3. Hoffman LK, Ehrmann DA 2008 Cardiometabolic features of polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab 4:215-222 (Pubitemid 351430905)
4. Dunaif A, Segal KR, Futterweit W, Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174 (Pubitemid 19250404)
5. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J 1999 Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141-146 (Pubitemid 29028311)
6. Legro RS, Kunselman AR, Dodson WC, Dunaif A 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165-169 (Pubitemid 29036695)
7. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T 2008 Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 52:686-717
8. Hla KM, Young T, Finn L, Peppard PE, Szklo-Coxe M, Stubbs M 2008 Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. Sleep 31:795-800 (Pubitemid 351810508)
9. Tasali E, Ip MS 2008 Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc 5:207-217 (Pubitemid 351237880)
10. Lévy P, Bonsignore MR, Eckel J 2009 Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 34:243-260
11. Punjabi NM, Beamer BA 2009 Alterations in glucose disposal in sleep-disordered breathing. Am J Respir Crit Care Med 179:235-240
12. Aronsohn RS, Whitmore H, Van Cauter E, Tasali E 2010 Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med 181:507-513
13. Fogel RB, Malhotra A, Pillar G, Pittman SD, Dunaif A, White DP 2001 Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 86:1175-1180 (Pubitemid 32323001)
14. Vgontzas AN, Legro RS, Bixler EO, Grayev A, Kales A, Chrousos GP 2001 Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 86:517-520 (Pubitemid 32207453)
15. Gopal M, Duntley S, Uhles M, Attarian H 2002 The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome. Sleep Med 3:401-404 (Pubitemid 35189927)
16. Tasali E, Van Cauter E, Hoffman L, Ehrmann DA 2008 Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome. J Clin Endocrinol Metab 93:3878-3884
17. Tasali E, Van Cauter E, Ehrmann DA 2006 Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. J Clin Endocrinol Metab 91:36-42 (Pubitemid 43069114)
18. Bergman RN 2005 Minimal model: perspective from 2005. Horm Res 64(Suppl 3):8-15
19. Weaver TE 2006 Adherence to positive airway pressure therapy. Curr Opin Pulm Med 12:409-413 (Pubitemid 44624599)
20. Iber C, Ancoli-Israel S, Chesson A, Quan SF 2007 The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specification. Darien, IL: American Academy of Sleep Medicine
21. 1992 EEG arousals: scoring rules and examples. A preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 15:173-184
22. 1999 Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22:667-689
23. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC 1973 Quantification of sleepiness: a new approach. Psychophysiology 10:431-436
24. Degaute JP, van de Borne P, Linkowski P, Van Cauter E 1991 Quantitative analysis of the 24-hour blood pressure and heart rate patterns in young men. Hypertension 18:199-210
25. Biston P, Van Cauter E, Ofek G, Linkowski P, Polonsky KS, Degaute JP 1996 Diurnal variations in cardiovascular function and glucose regulation in normotensive humans. Hypertension 28:863-871 (Pubitemid 26365531)
26. 1996 Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93:1043-1065
27. Van Helder T, Symons JD, Radomski MW 1993 Effects of sleep deprivation and exercise on glucose tolerance. Aviat Space Environ Med 64:487-492 (Pubitemid 23253961)
28. Weaver TE, Maislin G, Dinges DF, Bloxham T, George CF, Greenberg H, Kader G, Mahowald M, Younger J, Pack AI 2007 Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 30:711-719 (Pubitemid 46854758)
29. Weaver TE, Grunstein RR 2008 Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 5:173-178 (Pubitemid 351237875)
30. Unlühizarci K, Kele̊timur F, Bayram F, Sahin Y, Tutů A 1999 The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 51:231-236 (Pubitemid 29378909)
31. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, Zanolin E, Muggeo M 2000 Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 85:139-146 (Pubitemid 32268804)
32. Diamanti-Kandarakis E, Kouli C, Tsianateli T, Bergiele A 1998 Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol 138:269-274 (Pubitemid 28154775)
33. Ehrmann DA, Cavaghan MK, Imperial J, Sturis J, Rosenfield RL, Polonsky KS 1997 Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:524-530 (Pubitemid 27068623)
34. Crave JC, Fimbel S, Lejeune H, Cugnardey N, Déchaud H, Pugeat M 1995 Effects of diet and metformin administration on sex hormone- binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab 80:2057-2062
35. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ 2009 Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 92:1966-1982
36. Harsch IA, Schahin SP, Radespiel-Tröger M, Weintz O, Jahreiss H, Fuchs FS, Wiest GH, Hahn EG, Lohmann T, Konturek PC, Ficker JH 2004 Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169:156-162 (Pubitemid 38114528)
37. Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T 2005 Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Archives of internal medicine 165:447-452 (Pubitemid 40280202)
38. Lam JC, Lam B, Yao TJ, Lai AY, Ooi CG, Tam S, Lam KS, Ip MS 2010 A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Respir J 35:138-145
39. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R 2008 Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 134:686-692
40. Henley DE, Buchanan F, Gibson R, Douthwaite JA, Wood SA, Woltersdorf WW, Catterall JR, Lightman SL 2009 Plasma apelin levels in obstructive sleep apnea and the effect of continuous positive airway pressure therapy. J Endocrinol 203:181-188
41. Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Collins B, Basta M, Pejovic S, Chrousos GP 2008 Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest 38:585-595 (Pubitemid 352019140)
42. Trenell MI, Ward JA, Yee BJ, Phillips CL, Kemp GJ, Grunstein RR, Thompson CH 2007 Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab 9:679-687 (Pubitemid 47261849)
43. Coughlin SR, Mawdsley L, Mugarza JA, Wilding JP, Calverley PM 2007 Cardiovascular and metabolic effects of CPAP in obese men with OSA. Eur Respir J 29:720-727 (Pubitemid 46554622)
44. Murri M, Alcázar-Ramírez J, Garrido-Sánchez L, Linde F, Alcaide J, Cardona F, Tinahones FJ 2009 Oxidative stress and metabolic changes after continuous positive airway pressure treatment according to previous metabolic disorders in sleep apnea-hypopnea syndrome patients. Transl Res 154:111-121
45. Davy KP, Orr JS 2009 Sympathetic nervous system behavior in human obesity. Neurosci Biobehav Rev 33:116-124
46. Narkiewicz K, Montano N, Cogliati C, van de Borne PJ, Dyken ME, Somers VK 1998 Altered cardiovascular variability in obstructive sleep apnea. Circulation 98:1071-1077 (Pubitemid 28420698)
47. Narkiewicz K, Somers VK 2003 Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 177:385-390 (Pubitemid 36337642)
48. Grassi G, Facchini A, Trevano FQ, Dell'Oro R, Arenare F, Tana F, Bolla G, Monzani A, Robuschi M, Mancia G 2005 Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension 46:321-325 (Pubitemid 41099164)
49. Somers VK, Dyken ME, Clary MP, Abboud FM 1995 Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897-1904
50. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK 1999 Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17:61-66 (Pubitemid 29086189)
51. Mills PJ, Kennedy BP, Loredo JS, Dimsdale JE, Ziegler MG 2006 Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. J Appl Physiol 100:343-348 (Pubitemid 43671127)
52. Hedner J, Darpö B, Ejnell H, Carlson J, Caidahl K 1995 Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J 8:222-229
53. Fletcher EC 2003 Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea. Sleep 26:15-19
54. Bratel T, Wennlund A, Carlström K 1999 Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med 93:1-7
55. Shiina K, Tomiyama H, Takata Y, Yoshida M, Kato K, Saruhara H, Hashimura Y, Matsumoto C, Asano K, Usui Y, Yamashina A 2010 Effects of CPAP therapy on the sympathovagal balance and arterial stiffness in obstructive sleep apnea. Respir Med 104:911-916
56. Roche F, Court-Fortune I, Pichot V, Duverney D, Costes F, Emonot A, Vergnon JM, Geyssant A, Lacour JR, Barthélémy JC 1999 Reduced cardiac sympathetic autonomic tone after long-term nasal continuous positive airway pressure in obstructive sleep apnoea syndrome. Clin Physiol 19:127-134 (Pubitemid 29137599)
57. Sweeney G 2010 Cardiovascular effects of leptin. Nat Rev Cardiol 7:22-29
58. Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK 2000 Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 279:H234-H237 (Pubitemid 30616665)
59. Saarelainen S, Lahtela J, Kallonen E 1997 Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin. J Sleep Res 6:146-147 (Pubitemid 27300274)
60. Ip MS, Lam KS, Ho C, Tsang KW, Lam W 2000 Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118:580-586
61. Harsch IA, Konturek PC, Koebnick C, Kuehnlein PP, Fuchs FS, Pour Schahin S, Wiest GH, Hahn EG, Lohmann T, Ficker JH 2003 Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22:251-257 (Pubitemid 36986993)
62. Whitworth JA, Williamson PM, Mangos G, Kelly JJ 2005 Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag 1:291-299
63. Born J, Muth S, Fehm HL 1988 The significance of sleep onset and slow wave sleep for nocturnal release of growth hormone (GH) and cortisol. Psychoneuroendocrinology 13:233-243
64. Follenius M, Brandenberger G, Bandesapt JJ, Libert JP, Ehrhart J 1992 Nocturnal cortisol release in relation to sleep structure. Sleep 15:21-27
65. Gronfier C, Luthringer R, Follenius M, Schaltenbrand N, Macher JP, Muzet A, Brandenberger G 1997 Temporal relationships between pulsatile cortisol secretion and electroencephalographic activity during sleep in man. Electroencephalogr Clin Neurophysiol 103:405-408 (Pubitemid 27382151)
66. Vgontzas AN, Pejovic S, Zoumakis E, Lin HM, Bentley CM, Bixler EO, Sarrigiannidis A, Basta M, Chrousos GP 2007 Hypothalamicpituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. J Clin Endocrinol Metab 92:4199-4207 (Pubitemid 350074732)
67. Henley DE, Russell GM, Douthwaite JA, Wood SA, Buchanan F, Gibson R, Woltersdorf WW, Catterall JR, Lightman SL 2009 Hypothalamic- pituitary-adrenal axis activation in obstructive sleep apnea: the effect of continuous positive airway pressure therapy. J Clin Endocrinol Metab 94:4234-4242
68. Alajmi M, Mulgrew AT, Fox J, Davidson W, Schulzer M, Mak E, Ryan CF, Fleetham J, Choi P, Ayas NT 2007 Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 185:67-72 (Pubitemid 46571874)